In May 2021, the Milner Institute sought collaborative project proposals from CRUK Cambridge Centre researchers and clinicians with multiomic oncology data sets that would benefit from interrogation using advanced computational research approaches including machine learning. Two complementary projects were selected, each focusing on different aspects of renal cell carcinoma, and the Milner Institute has now released video interviews describing how these projects went.
The team behind the success of one the country’s largest science and innovation park has announced its plans to grow and double the number of people employed on site as it celebrates a decade of delivering jobs and investment in the South East.
The UK is a global player in the health arena. It holds a unique position at the sharp end of scientific discovery and the development of effective treatments. The country’s rapidly expanding life sciences sector has the potential to transform outcomes for millions of people whose lives are affected by a wide range of debilitating conditions and to deliver the strong growth that the economy needs in order to recover from Covid and the subsequent financial downturn. So why then would we slow this progress by refusing to fund promising emerging companies for the simple reason that their founders are women?
The Cell and Gene Therapy Catapult (CGTC) Skills Team came together in 2021 to address the critical skills gap in advanced therapies in the UK by creating and facilitating the use of various skills programmes to engage new talent and upskill existing talent. If you have spoken to one of the Skills Team or have seen a presentation recently, you will be familiar with the Skills Demand Survey which was published in 2021.
In recent years, diversity and inclusion have been thrust front and centre of the conversation for many life sciences organisations. The importance of building a thriving, diverse workplace has been made evident, with research showing that diverse, inclusive teams, are not only more innovative, they’re also more engaging and creative. The life sciences sector is an industry built on collaboration, creativity and innovation, providing ground-breaking solutions to some of modern science’s most pressing problems.
BioScience Managers, the international healthcare investment firm, is pleased to announce the appointment of David Atkins MBA PhD in the role of Managing Partner. Working alongside founder and Managing Partner, Jeremy Curnock Cook, David will be responsible for driving the future growth of BioScience Managers in new and existing geographies and to build on successes in digital health.
Funded by an additional £10.65 million from the UK Government’s Vaccine Taskforce, the Centre and Training Academy will upskill the future RNA workforce and support the development, scale-up and manufacture of new RNA therapies and vaccines.
Coulter Partners, the global experts in Executive Search and Leadership Development in Life Sciences, Health and Tech, and Differing Minds, Neurodiversity training and consulting specialist, are delighted to announce a partnership agreement. Coulter Partners will collaborate with Differing Minds to learn how to better support neurodivergent people and embrace Neurodiversity in executive search.